Literature DB >> 26668646

Effects of thymosin β4 on a rat model of severe acute pancreatitis.

Xiaobo He1, Jia Yu1, Wenyi Guo1, Teng Zuo1, Qiao Shi1, Kailiang Zhao1, Weixing Wang1.   

Abstract

The aim of the present study was to investigate the effects of thymosin β4 on a rat model of severe acute pancreatitis (SAP) induced by sodium taurocholate (STC) and the underlying mechanism. SAP was induced by the retrograde infusion of 5% STC (1 ml/kg) into the bile-pancreatic duct. In certain rats, thymosin β4 (30 mg/kg) was administered intraperitoneally 30 min prior to the infusion of STC. The severity of pancreatitis was evaluated by the measurement of serum amylase, lipase, tumor necrosis factor-α, interleukin (IL)-1β, IL-6 and myeloperoxidase (MPO) levels, and histological grading. Nuclear factor (NF)-κB activation was evaluated by immunohistochemistry and western blot analysis. Intercellular adhesion molecule (ICAM)-1 protein expression in the pancreas was studied using western blot analysis. Prophylactic administration of thymosin β4 was found to attenuate serum amylase and lipase activity and the serum concentrations of proinflammatory cytokines. In addition, it attenuated pathological pancreatic injury, pancreatic MPO activity, and the activation of NF-κB and ICAM-1 in the pancreas. These results suggest that thymosin β4 exerts a protective effect against STC-induced pancreatic injury.

Entities:  

Keywords:  acute pancreatitis; cytokine; inflammation; neutrophil infiltration; thymosin β4

Year:  2015        PMID: 26668646      PMCID: PMC4665812          DOI: 10.3892/etm.2015.2798

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  44 in total

Review 1.  Cytokine storm in acute pancreatitis.

Authors:  Rohit Makhija; Andrew N Kingsnorth
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

Review 2.  Thymosin beta4 and its posttranslational modifications.

Authors:  E Hannappel
Journal:  Ann N Y Acad Sci       Date:  2010-04       Impact factor: 5.691

3.  Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis.

Authors:  Marie Louise Malmstrøm; Mark Berner Hansen; Anders Møller Andersen; Annette Kjær Ersbøll; Ole Haagen Nielsen; Lars Nannestad Jørgensen; Srdan Novovic
Journal:  Pancreas       Date:  2012-03       Impact factor: 3.327

4.  Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells.

Authors:  K M Malinda; A L Goldstein; H K Kleinman
Journal:  FASEB J       Date:  1997-05       Impact factor: 5.191

5.  The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients.

Authors:  Terry Treadwell; Hynda K Kleinman; David Crockford; Mark A Hardy; Giorgio T Guarnera; Allan L Goldstein
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

6.  Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice.

Authors:  Deborah Philp; Mahnaz Badamchian; Brooke Scheremeta; Mychi Nguyen; Allan L Goldstein; Hynda K Kleinman
Journal:  Wound Repair Regen       Date:  2003 Jan-Feb       Impact factor: 3.617

7.  NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response.

Authors:  Xueqing Chen; Baoan Ji; Bing Han; Stephen A Ernst; Diane Simeone; Craig D Logsdon
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

8.  Pathogenic role of myeloperoxidase in acute pancreatitis.

Authors:  Serge Chooklin; Andriy Pereyaslov; Ihor Bihalskyy
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2009-12

9.  Activation of nuclear factor-κB in acinar cells increases the severity of pancreatitis in mice.

Authors:  Haojie Huang; Yan Liu; Jaroslaw Daniluk; Sebastian Gaiser; Jun Chu; Huamin Wang; Zhao-Shen Li; Craig D Logsdon; Baoan Ji
Journal:  Gastroenterology       Date:  2012-10-03       Impact factor: 22.682

10.  Development of thymosin beta4 for treatment of patients with ischemic heart disease.

Authors:  David Crockford
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.